Brevan Howard Capital Management’s Summit Therapeutics SMMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.23M	Buy	+104,660	New	+$2.23M	0.01%	615
2024 Q3	–	Sell	-31,214	Closed	-$243K	–	1366
2024 Q2	$243K	Buy	+31,214	New	+$243K	﹤0.01%	784